Background: Cancer stem cells (CSCs) have a high tumorigenic ability to form patient-
derived tumor xenografts (PDXs). PDXs are an attractive pre-clinical model, but gene …

Background/Aim: Patient-derived xenografting (PDX) of human colorectal cancer (CRC) is
the preferred experimental model to study tumor response to therapeutic agents. Gradually …

The aim of this study was to identify cancer stem cells (CSC) from three hepatocellular
carcinoma (HCC) cell lines and to screen for specific microRNAs (miRNAs) regulating …

Background: Colorectal cancer (CRC) is one of the most prevalent cancers in the world.
Cancer stem cells (CSC) have been reported in many human tumors and are thought to be …

Increasing evidence has suggested cancer stem cells (CSCs) are considered to be
responsible for cancer formation, recurrence, and metastasis. Recently, many studies have …

Colorectal cancer (CRC) is one of the major causes of cancer-related mortality worldwide.
Recent studies revealed that there is a relationship between CRC occurrence and …

Purpose The aim of this study was to perform radiotheranostics with radioiodinated
monoclonal antibodies (mAbs) for targeting cancer stem cells (CSCs) in human colorectal …

Many antitumor therapies affect rapidly dividing cells. However, tumor proliferation may be
driven by cancer stem cells (CSCs), which divide slowly and are relatively resistant to …

The purpose of this study was to investigate the effect of chemoresistant cancer-associated
fibroblasts (R-CAFs) against cisplatin (DDP) on colorectal cancer (CRC) progression. First …

Recent studies show that cancers may originate from special cells named cancer stem cells
(CSCs). As miRNAs have a prominent role in regulating cell activities, a question arise, that …